Psychedelics meet human brain organoids: insights into proteomics and potential for Alzheimer's disease treatment.
Front Dement – August 04, 2025
Source: PubMed Central
Summary
Psychedelic compounds appear to positively reshape key proteins in human brain cells, offering a novel avenue for Alzheimer's treatment. Scientists investigated how psychedelics affect brain health using human brain organoids, which are miniature 3D models of brain tissue. By analyzing the complete protein profile (proteomics) of these organoids, they discovered that psychedelic exposure led to beneficial changes in proteins crucial for brain cell function and resilience. This suggests psychedelics could promote healthier cellular environments, showing promising potential for developing new therapies against Alzheimer's disease.
Abstract
Psychedelics meet human brain organoids: insights into proteomics and potential for Alzheimer's disease treatment.